HK1013652A1 - Oxazoloquinolinone derivatives their preparation and their use in theraphy - Google Patents

Oxazoloquinolinone derivatives their preparation and their use in theraphy

Info

Publication number
HK1013652A1
HK1013652A1 HK98114972A HK98114972A HK1013652A1 HK 1013652 A1 HK1013652 A1 HK 1013652A1 HK 98114972 A HK98114972 A HK 98114972A HK 98114972 A HK98114972 A HK 98114972A HK 1013652 A1 HK1013652 A1 HK 1013652A1
Authority
HK
Hong Kong
Prior art keywords
theraphy
preparation
oxazoloquinolinone
derivatives
oxazoloquinolinone derivatives
Prior art date
Application number
HK98114972A
Other languages
English (en)
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of HK1013652A1 publication Critical patent/HK1013652A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
HK98114972A 1994-09-05 1998-12-23 Oxazoloquinolinone derivatives their preparation and their use in theraphy HK1013652A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
HK1013652A1 true HK1013652A1 (en) 1999-09-03

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98114972A HK1013652A1 (en) 1994-09-05 1998-12-23 Oxazoloquinolinone derivatives their preparation and their use in theraphy

Country Status (28)

Country Link
US (1) US5641785A (xx)
EP (1) EP0699680B1 (xx)
JP (1) JP4225585B2 (xx)
KR (1) KR100392523B1 (xx)
CN (1) CN1055472C (xx)
AT (1) ATE190311T1 (xx)
AU (1) AU687591B2 (xx)
CA (1) CA2157427C (xx)
CZ (1) CZ286128B6 (xx)
DE (1) DE69515402T2 (xx)
DK (1) DK0699680T3 (xx)
ES (1) ES2145886T3 (xx)
FI (1) FI110945B (xx)
FR (1) FR2724171B1 (xx)
GR (1) GR3033554T3 (xx)
HK (1) HK1013652A1 (xx)
HU (1) HU218587B (xx)
IL (1) IL115276A (xx)
NO (1) NO306617B1 (xx)
NZ (1) NZ272920A (xx)
PL (1) PL184412B1 (xx)
PT (1) PT699680E (xx)
RU (1) RU2141482C1 (xx)
SI (1) SI0699680T1 (xx)
SK (1) SK281867B6 (xx)
TW (1) TW356467B (xx)
UA (1) UA41916C2 (xx)
ZA (1) ZA957414B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
AU2008226649B2 (en) * 2007-03-09 2013-08-01 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
FI954141A (fi) 1996-03-06
NO953458L (no) 1996-03-06
NO953458D0 (no) 1995-09-04
DE69515402D1 (de) 2000-04-13
RU2141482C1 (ru) 1999-11-20
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
US5641785A (en) 1997-06-24
SK108995A3 (en) 1996-06-05
IL115276A (en) 1998-12-06
HU218587B (hu) 2000-10-28
EP0699680A1 (fr) 1996-03-06
DE69515402T2 (de) 2000-10-19
ATE190311T1 (de) 2000-03-15
SK281867B6 (sk) 2001-08-06
EP0699680B1 (fr) 2000-03-08
FR2724171A1 (fr) 1996-03-08
CZ286128B6 (cs) 2000-01-12
KR960010648A (ko) 1996-04-20
ES2145886T3 (es) 2000-07-16
FI954141A0 (fi) 1995-09-04
FR2724171B1 (fr) 1997-01-03
PL310273A1 (en) 1996-03-18
SI0699680T1 (en) 2000-10-31
IL115276A0 (en) 1996-01-19
DK0699680T3 (da) 2000-08-21
AU3041595A (en) 1996-03-21
GR3033554T3 (en) 2000-09-29
CA2157427A1 (en) 1996-03-06
HU9502578D0 (en) 1995-11-28
AU687591B2 (en) 1998-02-26
FI110945B (fi) 2003-04-30
TW356467B (en) 1999-04-21
NZ272920A (en) 1998-03-25
JP4225585B2 (ja) 2009-02-18
CN1128763A (zh) 1996-08-14
CN1055472C (zh) 2000-08-16
CA2157427C (en) 2010-06-01
CZ226295A3 (en) 1996-03-13
KR100392523B1 (ko) 2003-11-12
NO306617B1 (no) 1999-11-29
JPH0899881A (ja) 1996-04-16
ZA957414B (en) 1996-04-15
HUT73435A (en) 1996-07-29
PT699680E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
AU8343391A (en) Hair treatment composition
FI945703A0 (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
TW280773B (xx)
ATE208621T1 (de) Stabilisierung der prostaglandinzusammensetzungen
IL119828A0 (en) Substituted triazine derivatives their preparation and use
ATE160148T1 (de) Sonnenfilter, diese enthaltende kosmetische lichtschutzzusammensetzungen sowie deren verwendung
HK1013652A1 (en) Oxazoloquinolinone derivatives their preparation and their use in theraphy
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
GR3033123T3 (en) Tricyclic derivatives, their preparation, their use in the preparation of optically active or racemic colchicine, thiocolchicine and analogues or derivatives, and intermediates
FI951323A (fi) Polyjodatut yhdisteet, menetelmä niiden valmistamiseksi ja diagnostiset koostumukset
EP0512744A3 (en) Hair treatment composition containing a perfluoropolyether compound and a pearlescing agent
ZA93292B (en) Alkyl derivatives of trazodone
FI912269A (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
FR2648813B1 (fr) Nouveaux derives terpeniques, leur preparation et leur emploi

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20150831